# American Rebel Holdings Inc: overview AREB · OTC · CIK 1648087 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/areb.md) · [Financials](/companies/areb/financials.md) · [Filings](/companies/areb/filings.md) · [Insiders](/companies/areb/insiders.md) Latest reported revenue: [$2.0m](/filings/0001493152-26-036917.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-036917). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [2,338](/filings/0001493152-25-021519.md) | [1,783 d](/filings/0001493152-26-014291.md) | [2,511](/filings/0001493152-26-022768.md) | [2,843](/filings/0001493152-26-036917.md) | [1,878](/filings/0001493152-25-021519.md) | [2,291 d](/filings/0001493152-26-014291.md) | [1,985](/filings/0001493152-26-022768.md) | [1,986](/filings/0001493152-26-036917.md) | | Gross margin | % | [(21.3%)](/filings/0001493152-25-021519.md) | [(27.7%) d](/filings/0001493152-26-014291.md) | [11.5%](/filings/0001493152-26-022768.md) | [(1.1%)](/filings/0001493152-26-036917.md) | [(10.5%)](/filings/0001493152-25-021519.md) | [(11.2%) d](/filings/0001493152-26-014291.md) | [(19.8%)](/filings/0001493152-26-022768.md) | [(7.9%)](/filings/0001493152-26-036917.md) | | Operating margin | % | [(44.5%)](/filings/0001493152-25-021519.md) | [(277.8%) d](/filings/0001493152-26-014291.md) | [(118.1%)](/filings/0001493152-26-022768.md) | [(147.7%)](/filings/0001493152-26-036917.md) | [(196.0%)](/filings/0001493152-25-021519.md) | [(171.0%) d](/filings/0001493152-26-014291.md) | [(208.7%)](/filings/0001493152-26-022768.md) | [(238.2%)](/filings/0001493152-26-036917.md) | | Net margin | % | [(74.8%)](/filings/0001493152-25-021519.md) | [(443.1%) d](/filings/0001493152-26-014291.md) | [(201.5%)](/filings/0001493152-26-022768.md) | [(638.1%)](/filings/0001493152-26-036917.md) | [(278.6%)](/filings/0001493152-25-021519.md) | [(257.5%) d](/filings/0001493152-26-014291.md) | [(345.2%)](/filings/0001493152-26-022768.md) | [(300.5%)](/filings/0001493152-26-036917.md) | | Diluted EPS | $ per share | [(3032.24)](/filings/0001493152-25-021519.md) | not reported | [(937997.93)](/filings/0001493152-26-022768.md) | [(213385.21)](/filings/0001493152-26-036917.md) | [(32.44)](/filings/0001493152-25-021519.md) | not reported | [(71.28)](/filings/0001493152-26-022768.md) | [(0.59)](/filings/0001493152-26-036917.md) | | Free cash flow | $k | not reported | not reported | [(549)](/filings/0001493152-26-022768.md) | [(2,853) d](/filings/0001493152-26-036917.md) | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1.0](/filings/0001493152-23-012360.md) | [7.9](/filings/0001493152-25-004183.md) | [16.0](/filings/0001641172-25-003346.md) | [11.4](/filings/0001493152-26-014291.md) | [9.5](/filings/0001493152-26-014291.md) | | Gross margin | % | [17.7%](/filings/0001493152-23-012360.md) | [(10.2%)](/filings/0001493152-25-004183.md) | [11.2%](/filings/0001641172-25-003346.md) | [(1.0%)](/filings/0001493152-26-014291.md) | [(2.1%)](/filings/0001493152-26-014291.md) | | Operating margin | % | [(335.6%)](/filings/0001493152-23-012360.md) | [(100.6%)](/filings/0001493152-25-004183.md) | [(54.8%)](/filings/0001641172-25-003346.md) | [(107.0%)](/filings/0001493152-26-014291.md) | [(155.0%)](/filings/0001493152-26-014291.md) | | Net margin | % | [(618.0%)](/filings/0001493152-23-012360.md) | [(126.9%)](/filings/0001493152-25-004183.md) | [(60.8%)](/filings/0001641172-25-003346.md) | [(154.2%)](/filings/0001493152-26-014291.md) | [(360.5%)](/filings/0001493152-26-014291.md) | | Diluted EPS | $ per share | [(3.14)](/filings/0001493152-23-012360.md) | [(33.76)](/filings/0001493152-25-004183.md) | [(857.02)](/filings/0001641172-25-003346.md) | [(12276404.46)](/filings/0001493152-26-014291.md) | [(63214.16)](/filings/0001493152-26-014291.md) | | Free cash flow | $m | not reported | [(7.7)](/filings/0001493152-25-004183.md) | [(7.0)](/filings/0001641172-25-003346.md) | [(7.0)](/filings/0001493152-26-014291.md) | [(7.6)](/filings/0001493152-26-014291.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/areb/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [HARBOUR INVESTMENTS, INC.](/funds/810121.md) | 2026-06-30 | $1 | 2 | | New +2 | | [Farther Finance Advisors, LLC](/funds/1992825.md) | 2026-06-30 | $0 | 1 | | New +1 | ## Recent filings [All 425 filings](/companies/areb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-30 | 21:25 ET | [8-K](/filings/0001493152-26-049323.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-049323 | | 2026-10-14 | 11:14 ET | [8-K](/filings/0001493152-26-046949.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-046949 | | 2026-09-17 | 13:42 ET | [8-K](/filings/0001493152-26-043084.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-043084 | | 2026-09-09 | 19:23 ET | [8-K](/filings/0001493152-26-041817.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-041817 | | 2026-08-31 | 13:20 ET | [8-K](/filings/0001493152-26-040784.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-040784 | | 2026-08-10 | 17:24 ET | [10-Q](/filings/0001493152-26-036917.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036917 | | 2026-08-07 | 14:45 ET | [8-K](/filings/0001493152-26-036535.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-036535 | | 2026-08-04 | 14:22 ET | [8-K](/filings/0001493152-26-035971.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-035971 | | 2026-07-21 | 15:11 ET | [8-K](/filings/0001493152-26-034059.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034059 | | 2026-07-02 | 17:04 ET | [8-K](/filings/0001493152-26-031954.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-031954 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-014291.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/a005b85a-ab80-4064-9aad-3e830d3c215f) ## About the filer - CIK: 1648087 - Tickers: AREB, AREBW - Exchange: OTC - SIC code: 3490 Miscellaneous Fabricated Metal Products - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 06:13 ET. No prices; not investment advice.